Scriba Nanotecnologie

Indirizzo: Via di Corticella, 183, 40128
Bologna BO



Magnetic Diagnostic Assay for Neurodegenerative Diseases

MADIA will develop a cost-effective device for the analysis of CSF and blood samples for the detection of the already validated or innovative biomarkers, designed to become a reference Alzheimer’s and Parkinson diseases diagnostic tool in the standard clinical practice with good premises to function in the point of care regime.

Scriba Nanotecnologie SRL

Via di Corticella 183/8 - 40128 Bologna (IT)

P.IVA IT02542781204
REA: 447542